Navigation Links
Advances in Cosmesis Increase Amputee Acceptance of Prosthesis and Orthotics Devices, Finds Frost & Sullivan
Date:12/12/2012

MOUNTAIN VIEW, Calif., Dec. 12, 2012 /PRNewswire/ -- The orthotics and prosthetics (O&P) industry is becoming a fertile ground for innovation because of the expanding patient pool of the elderly and disabled as well as numerous technological breakthroughs. The improving quality of O&P devices and services due to regular clinical interventions and integration of the interpreted data into patient care have considerably enhanced their uptake.

New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Advances in Bionic Prosthesis and Orthotics finds that the O&P industry is experiencing a blend of multiple streams of science and technology. Consequently, market participants must strategize to align competencies, capabilities and resources to expand their market share.

If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Advances in plastic fabrication, structures and materials help manufacturers produce better artificial limbs at a much quicker pace," said Technical Insights Research Analyst Saju John Mathew. "Further, the advent of microprocessors has transformed the overall prosthetics landscape."

Currently, many versions of prosthesis can be developed to fit a patient's varying motor skills, facilitating better functionality and integration with the patient's needs. Superior cosmesis enables the matching of the prosthetics with the patient's sound side to camouflage any disability.

However, there is always a risk of microbial infection during surgical insertion of a prosthetic in the body and this discourages its use. The Food and Drug Administration (FDA) can also peg back the newly conceived technology/product by delaying its commercial launch. In some instances, technology developers prefer to conduct their R&D overseas, citing regulatory delays.

O&P devices, specifically related to neurostimulation technologies, are still at an early stage of commercialization. Developers need to ensure smoother regulatory approvals to attract investors and partners, and to gain global market shares.

As the technology gets smarter and new materials and structures are invented, biocompatibility issues will be resolved. Miniaturization will further enhance the appeal of O&P devices among patients and boost the technology's adoption.

"A strong R&D network under one umbrella can help developers complement existing technologies and explore other applications," noted Mathew. "Additionally, a hassle-free R&D environment aids uninterrupted funding and technology transfer between partners to enhance the value of the developed technology/product."

Advances in Bionic Prosthesis and Orthotics, part of the Technical Insights subscription, outlines the R&D platform and the necessary factors required for the growth of the O&P industry. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Advances in Bionic Prosthesis and Orthotics    
D2F7-TI

Contact:    
Britni Myers    
Corporate Communications – North America    
P: 210.477.8481    
F: 210.348.1003    
E: britni.myers@frost.com    

http://www.frost.com
http://www.technicalinsights.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
2. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
3. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
6. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
7. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
8. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
9. Advances in Delivery to the Central Nervous System
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
Breaking Medicine News(10 mins):